Reduced Coffee Consumption Among Individuals with Primary Sclerosing Cholangitis but Not Primary Biliary Cirrhosis

Overview

Journal Clin Gastroenterol Hepatol

Specialty Gastroenterology

Date 2014 Jan 21

PMID 24440215

Citations 14

Authors

Craig Lammert

Brian D Juran

Erik Schlicht

Xiao Xie

Elizabeth J Atkinson

Mariza de Andrade

Konstantinos N Lazaridis

Affiliations

Soon will be listed here.

Abstract

Background & Aims: Coffee consumption has been associated with decreased risk of liver disease and related outcomes. However, coffee drinking has not been investigated among patients with cholestatic autoimmune liver diseases, primary biliary cirrhosis (PBC), or primary sclerosing cholangitis (PSC). We investigated the relationship between coffee consumption and risk of PBC and PSC in a large North American cohort.

Methods: Lifetime coffee drinking habits were determined from responses to questionnaires from 606 patients with PBC, 480 with PSC, and 564 healthy volunteers (controls). Patients (those with PBC or PSC) were compared with controls by using the Wilcoxon rank sum test for continuous variables and c(2) method for discrete variables. Logistic regression was used to analyze the estimate of the effects of different coffee parameters (time, frequency, and type of coffee consumption) after adjusting for age, sex, smoking status, and education level.

Results: Patients with PBC and controls did not differ in coffee parameters. However, 24% of patients with PSC had never drunk coffee compared with 16% of controls (P < .05), and only 67% were current drinkers compared with 77% of controls (P < .05). Patients with PSC also consumed fewer lifetime cups per month (45 vs 47 for controls, P < .05) and spent a smaller percentage of their lifetime drinking coffee (46.6% vs 66.7% for controls, P < .05). These differences remained significant in a multivariate model. Among PSC patients with concurrent ulcerative colitis, coffee protected against proctocolectomy (hazard ratio, 0.34; P < .001).

Conclusions: Coffee consumption is lower among patients with PSC, but not PBC, compared with controls.

Citing Articles

Coffee, adenosine, and the liver.

Dranoff J Purinergic Signal. 2023; 20(1):21-28.

PMID: 37755557 PMC: 10828332. DOI: 10.1007/s11302-023-09968-5.

The microbiota and the gut-liver axis in primary sclerosing cholangitis.

Hov J, Karlsen T Nat Rev Gastroenterol Hepatol. 2022; 20(3):135-154.

PMID: 36352157 DOI: 10.1038/s41575-022-00690-y.

Missing Causality and Heritability of Autoimmune Hepatitis.

Czaja A Dig Dis Sci. 2022; 68(4):1585-1604.

PMID: 36261672 DOI: 10.1007/s10620-022-07728-w.

Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies.

Aune D, Sen A, Norat T, Riboli E, Folseraas T Sci Rep. 2021; 11(1):10646.

PMID: 34017024 PMC: 8137938. DOI: 10.1038/s41598-021-90175-w.

Environmental risk factors are associated with autoimmune hepatitis.

Lammert C, Chalasani S, Atkinson E, McCauley B, Lazaridis K Liver Int. 2021; 41(10):2396-2403.

PMID: 33978301 PMC: 8496440. DOI: 10.1111/liv.14944.

References

Blackwell C, Jonsdottir K, Hanson M, Todd W, Chaudhuri A, Mathew B . Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet. 1986; 2(8501):284-5. DOI: 10.1016/s0140-6736(86)92103-3. View

Pan A, Malik V, Hao T, Willett W, Mozaffarian D, Hu F . Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies. Int J Obes (Lond). 2013; 37(10):1378-85. PMC: 3628978. DOI: 10.1038/ijo.2012.225. View

Weinstock G . Genomic approaches to studying the human microbiota. Nature. 2012; 489(7415):250-6. PMC: 3665339. DOI: 10.1038/nature11553. View

Juran B, Atkinson E, Schlicht E, Larson J, Ellinghaus D, Franke A . Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis. Liver Int. 2010; 31(6):785-91. PMC: 3139245. DOI: 10.1111/j.1478-3231.2010.02420.x. View

Ruhl C, Everhart J . Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2005; 128(1):24-32. DOI: 10.1053/j.gastro.2004.09.075. View

. Cigarette smoking among adults--United States, 2004. MMWR Morb Mortal Wkly Rep. 2005; 54(44):1121-4. View

Klatsky A, Armstrong M . Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol. 1992; 136(10):1248-57. DOI: 10.1093/oxfordjournals.aje.a116433. View

Andersen I, Tengesdal G, Lie B, Boberg K, Karlsen T, Hov J . Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis. Clin Gastroenterol Hepatol. 2013; 12(6):1019-28. DOI: 10.1016/j.cgh.2013.09.024. View

Andersen L, Jacobs Jr D, Carlsen M, Blomhoff R . Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr. 2006; 83(5):1039-46. DOI: 10.1093/ajcn/83.5.1039. View

10.

Loftus Jr E, Sandborn W, Tremaine W, Mahoney D, Zinsmeister A, Offord K . Primary sclerosing cholangitis is associated with nonsmoking: a case-control study. Gastroenterology. 1996; 110(5):1496-502. DOI: 10.1053/gast.1996.v110.pm8613055. View

11.

Cohen A, Lee D, Long M, Kappelman M, Martin C, Sandler R . Dietary patterns and self-reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2012; 58(5):1322-8. PMC: 3552110. DOI: 10.1007/s10620-012-2373-3. View

12.

Matsuura H, Mure K, Nishio N, Kitano N, Nagai N, Takeshita T . Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol. 2012; 22(2):160-6. PMC: 3798595. DOI: 10.2188/jea.je20110068. View

13.

Thom S, Blackwell C, MacCallum C, WEIR D, Brettle R, Kinane D . Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol Immunol. 1989; 1(6-7):401-5. DOI: 10.1111/j.1574-6968.1989.tb02428.x. View

14.

Vitaglione P, Morisco F, Mazzone G, Amoruso D, Ribecco M, Romano A . Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology. 2010; 52(5):1652-61. DOI: 10.1002/hep.23902. View

15.

Zein C, Beatty K, Post A, Logan L, Debanne S, McCullough A . Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment. Hepatology. 2006; 44(6):1564-71. DOI: 10.1002/hep.21423. View

16.

Lammert C, Nguyen D, Juran B, Schlicht E, Larson J, Atkinson E . Questionnaire based assessment of risk factors for primary biliary cirrhosis. Dig Liver Dis. 2013; 45(7):589-94. PMC: 3686972. DOI: 10.1016/j.dld.2013.01.028. View

17.

Noordzij M, Uiterwaal C, Arends L, Kok F, Grobbee D, Geleijnse J . Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens. 2005; 23(5):921-8. DOI: 10.1097/01.hjh.0000166828.94699.1d. View

18.

Juran B, Hirschfield G, Invernizzi P, Atkinson E, Li Y, Xie G . Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. Hum Mol Genet. 2012; 21(23):5209-21. PMC: 3490520. DOI: 10.1093/hmg/dds359. View

19.

Lindor K, Gershwin M, Poupon R, Kaplan M, Bergasa N, Heathcote E . Primary biliary cirrhosis. Hepatology. 2009; 50(1):291-308. DOI: 10.1002/hep.22906. View

20.

Nakayama T, Oishi K . Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses. FEMS Microbiol Lett. 2013; 343(2):161-8. DOI: 10.1111/1574-6968.12142. View